| Name | Title | Contact Details |
|---|
Specialized Dental Partners provides a supported integrated care model that will help you attract more patients, provide next level care, and realize the benefits of retirement while you are still building and benefitting from your career.
EIS Analytics is a Vancouver, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kind and Total Health System is a Alhambra, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Bridge Fitness is a Crystal Lake, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.